When clinical execution is outsourced, accountability does not transfer.
Sponsors remain responsible for oversight of delegated trial activities.
Effective oversight requires structure. Responsibilities must be defined, decisions must be traceable, and accountability must be documented.
Silvertree BioLife helps sponsors move from general trial visibility to deliberate, structured oversight.
Our work focuses on three core areas: designing oversight models, identifying oversight gaps, and conducting targeted quality reviews when specific risks or concerns require deeper evaluation.
Silvertree BioLife helps sponsors move from general trial visibility to deliberate, structured oversight.
Our work focuses on three core areas: designing oversight models, identifying oversight gaps, and conducting targeted quality reviews when specific risks or concerns require deeper evaluation.
Oversight Gap Analysis
See where oversight is working — and where it is not.
Silvertree BioLife helps sponsors assess how oversight is designed, implemented, documented, and functioning across outsourced clinical trials.
Targeted Quality Reviews
Focus where the risk is.
Silvertree BioLife conducts targeted reviews of specific trial activities, vendors, sites, or processes to help sponsors understand what is happening, assess potential impact, and determine practical next steps.

Silvertree BioLife helps sponsors move from general trial visibility to deliberate, structured oversight.
Our work focuses on three core areas: designing oversight models, identifying oversight gaps, and conducting targeted quality reviews when specific risks or concerns require deeper evaluation.
Strengthen oversight before gaps become harder to address.
Whether you are preparing for study start-up, managing an active outsourced trial, or responding to oversight concerns, Silvertree BioLife can help assess where oversight is working and where it may need to be strengthened.
Silvertree BioLife
SPONSOR OVERSIGHT | CLINICAL TRIAL GOVERNANCE